JP2001509378A5 - - Google Patents

Download PDF

Info

Publication number
JP2001509378A5
JP2001509378A5 JP2000502165A JP2000502165A JP2001509378A5 JP 2001509378 A5 JP2001509378 A5 JP 2001509378A5 JP 2000502165 A JP2000502165 A JP 2000502165A JP 2000502165 A JP2000502165 A JP 2000502165A JP 2001509378 A5 JP2001509378 A5 JP 2001509378A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2000502165A
Other languages
Japanese (ja)
Other versions
JP4368522B2 (ja
JP2001509378A (ja
Filing date
Publication date
Priority claimed from US08/891,789 external-priority patent/US6103466A/en
Application filed filed Critical
Priority claimed from PCT/IB1998/001197 external-priority patent/WO1999002667A1/en
Publication of JP2001509378A publication Critical patent/JP2001509378A/ja
Publication of JP2001509378A5 publication Critical patent/JP2001509378A5/ja
Application granted granted Critical
Publication of JP4368522B2 publication Critical patent/JP4368522B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2000502165A 1997-07-14 1998-07-14 哺乳動物におけるダブルマスル化を引き起こすミオスタチン遺伝子の変異 Expired - Lifetime JP4368522B2 (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US08/891,789 US6103466A (en) 1997-07-14 1997-07-14 Double-muscling in mammals
US776198A 1998-01-15 1998-01-15
US08/891,789 1998-01-15
US09/007,761 1998-01-15
PCT/IB1998/001197 WO1999002667A1 (en) 1997-07-14 1998-07-14 Mutations in the myostation gene cause double-muscling in mammals

Publications (3)

Publication Number Publication Date
JP2001509378A JP2001509378A (ja) 2001-07-24
JP2001509378A5 true JP2001509378A5 (enExample) 2005-12-22
JP4368522B2 JP4368522B2 (ja) 2009-11-18

Family

ID=26677351

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000502165A Expired - Lifetime JP4368522B2 (ja) 1997-07-14 1998-07-14 哺乳動物におけるダブルマスル化を引き起こすミオスタチン遺伝子の変異

Country Status (13)

Country Link
US (1) US20030129171A1 (enExample)
EP (2) EP2045322B1 (enExample)
JP (1) JP4368522B2 (enExample)
AT (1) ATE442436T1 (enExample)
AU (1) AU756620B2 (enExample)
CA (1) CA2296434C (enExample)
CY (1) CY1116682T1 (enExample)
DE (1) DE69841139D1 (enExample)
DK (1) DK2045322T3 (enExample)
ES (1) ES2547858T3 (enExample)
NZ (1) NZ502523A (enExample)
PT (1) PT2045322E (enExample)
WO (1) WO1999002667A1 (enExample)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7566768B1 (en) 1995-10-26 2009-07-28 The Johns Hopkins University School Of Medicine Promyostatin peptides and methods of using same
US5994618A (en) 1997-02-05 1999-11-30 Johns Hopkins University School Of Medicine Growth differentiation factor-8 transgenic mice
US7393682B1 (en) 1993-03-19 2008-07-01 The Johns Hopkins University School Of Medicine Polynucleotides encoding promyostatin polypeptides
ES2201076T3 (es) 1993-03-19 2004-03-16 The Johns Hopkins University School Of Medicine Factor-8 de diferenciacion del crecimiento.
US7332575B2 (en) 1994-03-18 2008-02-19 The Johns Hopkins University School Of Medicine Growth differentiation factor-8 nucleic acid and polypeptide from aquatic species, and transgenic aquatic species
US6008434A (en) 1994-07-08 1999-12-28 Johns Hopkins University School Of Medicine Growth differentiation factor-11 transgenic mice
GB2333706A (en) * 1998-02-02 1999-08-04 Merck & Co Inc Method for increasing muscle mass in animals
US6369201B1 (en) * 1998-02-19 2002-04-09 Metamorphix International, Inc. Myostatin multimers
WO2000009667A1 (en) * 1998-08-14 2000-02-24 Board Of Regents, The University Of Texas System Calcineurin-dependent control of skeletal muscle fiber type
EP1147413B1 (en) * 1999-01-21 2006-04-05 Metamorphix, Inc. Growth differentiation factor inhibitors and uses therefor
KR100750695B1 (ko) * 1999-07-20 2007-08-22 파멕사 에이/에스 Gdf-8 활성을 하향-조절하는 방법
AU4889100A (en) * 1999-07-30 2001-02-01 Pfizer Products Inc. Myostatin regulatory region, nucleotide sequence determination and methods for its use
US7494817B2 (en) 2000-09-06 2009-02-24 Transnet Yx, Inc. Methods for genotype screening using magnetic particles
KR20020065509A (ko) * 2000-09-06 2002-08-13 티모시 에이. 호지 유전자이식 및 표적 돌연변이유발 스크리닝을 위한시스템, 방법 및 장치
EP1978110B1 (en) 2000-09-06 2010-05-26 Transnetyx, Inc. Computer-based method and system for screening genomic DNA
US7037501B2 (en) 2001-01-04 2006-05-02 Regents Of The University Of Minnesota Myostatin immnoconjugate
TWI329129B (en) 2001-02-08 2010-08-21 Wyeth Corp Modified and stabilized gdf propeptides and uses thereof
US7320789B2 (en) 2001-09-26 2008-01-22 Wyeth Antibody inhibitors of GDF-8 and uses thereof
AR047392A1 (es) 2002-10-22 2006-01-18 Wyeth Corp Neutralizacion de anticuerpos contra gdf 8 y su uso para tales fines
KR20130036378A (ko) * 2002-12-20 2013-04-11 암겐 인코포레이티드 미오스타틴을 저해하는 결합제
CA2512110A1 (en) 2002-12-31 2004-07-22 Mmi Genomics, Inc. Compositions, methods, and systems for inferring bovine breed
WO2004108157A2 (en) 2003-06-02 2004-12-16 Wyeth Use of myostatin (gdf8) inhibitors in conjunction with corticosteroids for treating neuromuscular disorders
ES2852549T3 (es) * 2005-02-09 2021-09-13 Sarepta Therapeutics Inc Composición antisentido para tratamiento de la atrofia muscular
EP1915397B1 (en) 2005-08-19 2015-01-14 Wyeth LLC Antagonist antibodies against gdf-8 and uses in treatment of als and other gdf-8-associated disorders
KR100872042B1 (ko) * 2005-09-14 2008-12-05 주식회사 바이오리더스 마이오스타틴을 발현하는 세포표면 발현벡터 및 상기벡터에 의해 형질전환된 미생물
GB2433320B (en) * 2005-12-16 2009-10-07 Norwegian University Of Life S Diagnostic method
CA2558160C (en) * 2006-06-30 2017-01-03 Oligos Etc., Inc. Antisense oligonucleotide targeting myostatin or fox01 for treatment of muscle wasting
KR100857861B1 (ko) * 2007-10-15 2008-09-11 주식회사 바이오리더스 Myo-2 펩타이드 중합체와 마이오스타틴의 융합단백질표면발현용 벡터 및 상기 벡터로 형질전환된 미생물
US10920242B2 (en) 2011-02-25 2021-02-16 Recombinetics, Inc. Non-meiotic allele introgression
CA2828239C (en) * 2011-02-25 2020-10-06 Recombinetics, Inc. Genetically modified animals and methods for making the same
US9528124B2 (en) 2013-08-27 2016-12-27 Recombinetics, Inc. Efficient non-meiotic allele introgression
US20130085139A1 (en) 2011-10-04 2013-04-04 Royal Holloway And Bedford New College Oligomers
CN104487453B (zh) 2012-06-15 2018-09-28 辉瑞公司 经改良的抗gdf-8的拮抗剂抗体及其用途
AR091482A1 (es) * 2012-06-21 2015-02-04 Recombinetics Inc Celulas modificadas geneticamente y metodos par su obtencion
SMT202100008T1 (it) 2013-05-06 2021-03-15 Scholar Rock Inc Composizioni e metodi per la modulazione di fattore di crescita
EP2960653A1 (en) * 2014-06-24 2015-12-30 Stichting Kwaliteitsgarantie Vleeskalversector Diagnostic kit and method for the identification of the manipulation of muscle mass in a domestic animal
MA41795A (fr) 2015-03-18 2018-01-23 Sarepta Therapeutics Inc Exclusion d'un exon induite par des composés antisens dans la myostatine
WO2017062835A2 (en) * 2015-10-09 2017-04-13 Sarepta Therapeutics, Inc. Compositions and methods for treating duchenne muscular dystrophy and related disorders
CN106472430A (zh) * 2016-10-21 2017-03-08 延边朝鲜族自治州农业科学院(延边特产研究所) 一种寒冷地区烟蚜茧蜂冬季保种方法
WO2019174560A1 (zh) * 2018-03-14 2019-09-19 必康生技(香港)有限公司 用于生物流体净化的组合物
CN110157818B (zh) * 2019-07-08 2023-04-25 云南东恒经贸集团猪育种有限公司 一种与猪眼肌高产性状相关的分子标记及其应用
AU2021390998A1 (en) * 2020-12-03 2023-06-29 Kyungsangbukdo (Kyungsangbukdo Livestock Research Institute) Transgenic animal having modified myostatin gene
CN120192396A (zh) * 2023-12-21 2025-06-24 江苏省农业科学院 一种肌肉生长抑制素mstn蛋白突变体及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4870009A (en) 1982-11-22 1989-09-26 The Salk Institute For Biological Studies Method of obtaining gene product through the generation of transgenic animals
GB8308235D0 (en) 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US4736866A (en) 1984-06-22 1988-04-12 President And Fellows Of Harvard College Transgenic non-human mammals
JPS6147500A (ja) 1984-08-15 1986-03-07 Res Dev Corp Of Japan キメラモノクロ−ナル抗体及びその製造法
EP0173494A3 (en) 1984-08-27 1987-11-25 The Board Of Trustees Of The Leland Stanford Junior University Chimeric receptors by dna splicing and expression
GB8422238D0 (en) 1984-09-03 1984-10-10 Neuberger M S Chimeric proteins
GB8607679D0 (en) 1986-03-27 1986-04-30 Winter G P Recombinant dna product
US5264558A (en) 1987-06-19 1993-11-23 The Regents Of The University Of California Single-chain monellin analog as a low calorie protein sweetner
DE3878468T2 (de) 1987-12-23 1993-06-09 Upjohn Co Chimarenglykoproteine, enthaltend immunogene segmente des humanen respiratorischen synzytialvirus.
US5633076A (en) 1989-12-01 1997-05-27 Pharming Bv Method of producing a transgenic bovine or transgenic bovine embryo
GB9021679D0 (en) 1990-10-05 1990-11-21 Gorman Scott David Antibody preparation
US5162209A (en) * 1991-01-18 1992-11-10 Beth Israel Hospital Association Synthesis of full-length, double-stranded dna from a single-stranded linear dna template
US5962316A (en) * 1992-10-16 1999-10-05 Cold Spring Harbor Laboratory Cell-cycle regulatory proteins, and uses related thereto
ES2201076T3 (es) * 1993-03-19 2004-03-16 The Johns Hopkins University School Of Medicine Factor-8 de diferenciacion del crecimiento.
AU704440B2 (en) * 1994-02-04 1999-04-22 Bio Merieux MSRV1 virus and MSRV2 pathogenic and/or infectious agent associated with multiple sclerosis, nucleic acid components and applications of same
WO1998033887A1 (en) * 1997-02-05 1998-08-06 The Johns Hopkins University School Of Medicine Growth differentiation factor-8

Similar Documents

Publication Publication Date Title
JP2001521254A5 (enExample)
JP2004515087A5 (enExample)
JP2001516990A5 (enExample)
JP2001509378A5 (enExample)
BRPI9917862A2 (enExample)
JP2001526919A5 (enExample)
JP2001518608A5 (enExample)
IT1298629B1 (it) Metodo e apparecchiatura per il trattamento di materiali tessili finiti
JP2001510967A5 (enExample)
JPH11260539A5 (enExample)
JP2501355C (enExample)
JP2583409C (enExample)
JP2562673C (enExample)
IN189001B (enExample)
JP2560727C (enExample)
JP2555292C (enExample)
JP2555013C (enExample)
JP2554737C (enExample)
JP2541218C (enExample)
JP2511516C (enExample)
CN3074692S (enExample)
CN3076976S (enExample)
CN3074052S (enExample)
CN3081368S (enExample)
CN3074906S (enExample)